<em>Patt Morrison</em> is known for its innovative discussions of local politics and culture, as well as its presentation of the effects of national and world news on Southern California.
Hosted by
Airs

This little pill goes to market, but does it cost $76 million or $1.3 billion? Is Big Pharma exaggerating the cost of creating drugs?




Pharmacy area of Wal-Mart store in Mount Prospect, Illinois
Pharmacy area of Wal-Mart store in Mount Prospect, Illinois
Tim Boyle/Getty Images

Listen to story

17:31
Download this story 8MB

The Pharmaceutical Research and Manufacturers of America (PhRMA), or Big Pharma, claims it cost as much at $1.3 billion to create and bring a new drug to market. The dollar estimation is important because the cost of R&D can be used to justify tax breaks, faster drug approvals, protection against generics and the availability of less expensive drugs from Canada. The logic goes something like this: If R&D costs are high, profit margins must be too or the industry can’t sustain. But the problem (say some critics) is that the numbers get a bit squishy and are not always easy to verify. A new study reveals that the cost of bringing a pill to market isn’t $1.3 billion, but is actually closer to $76 million. So if that’s true, will my bottle of pills cost a little less at the drug store?

Guests:

Michael Hiltzik, Pulitzer Prize-winning business columnist for the Los Angeles Times and author of Colossus: Hoover Dam and the Making of the American Century

Donald W. Light, professor of comparative health policy at the University of Medicine and Dentistry of New Jersey; visiting researcher at Princeton University